PTPRN and diabetes mellitus: Antibodies associated with diabetes mellitus (anti-GAD65, anti–ZnT8, anti–IA-2, islet cell antibody) were measured in 25 out of the 27 patients that developed diabetes mellitus following treatment with anti-PD-1 or anti-PD-L1.